Lansiaux A - Search Results

1

The antitumor drug F14512 enhances cisplatin and ionizing radiation effects in head and neck squamous carcinoma cell lines.

Mouawad F, Gros A, Rysman B, Bal-Mahieu C, Bertheau C, Horn S, Sarrazin T, Lartigau E, Chevalier D, Bailly C, Lansiaux A, Meignan S. Mouawad F, et al. Among authors: lansiaux a. Oral Oncol. 2014 Feb;50(2):113-9. doi: 10.1016/j.oraloncology.2013.11.003. Epub 2013 Nov 26. Oral Oncol. 2014. PMID: 24290982

2

Activity of the polyamine-vectorized anti-cancer drug F14512 against pediatric glioma and neuroblastoma cell lines.

Leblond P, Boulet E, Bal-Mahieu C, Pillon A, Kruczynski A, Guilbaud N, Bailly C, Sarrazin T, Lartigau E, Lansiaux A, Meignan S. Leblond P, et al. Among authors: lansiaux a. Invest New Drugs. 2014 Oct;32(5):883-92. doi: 10.1007/s10637-014-0132-3. Epub 2014 Jul 11. Invest New Drugs. 2014. PMID: 25008900

3

Human epidermal growth factor receptor 3 in head and neck squamous cell carcinomas.

Rysman B, Mouawad F, Gros A, Lansiaux A, Chevalier D, Meignan S. Rysman B, et al. Among authors: lansiaux a. Head Neck. 2016 Apr;38 Suppl 1:E2412-8. doi: 10.1002/hed.24367. Epub 2016 Feb 2. Head Neck. 2016. PMID: 26835877 Review.

4

Cilengitide targets pediatric glioma and neuroblastoma cells through cell detachment and anoikis induction.

Leblond P, Dewitte A, Le Tinier F, Bal-Mahieu C, Baroncini M, Sarrazin T, Lartigau E, Lansiaux A, Meignan S. Leblond P, et al. Among authors: lansiaux a. Anticancer Drugs. 2013 Sep;24(8):818-25. doi: 10.1097/CAD.0b013e328362edc5. Anticancer Drugs. 2013. PMID: 23728220

5

[A symphony for the camptothecins].

Lansiaux A, Bailly C. Lansiaux A, et al. Bull Cancer. 2003 Mar;90(3):239-45. Bull Cancer. 2003. PMID: 12801826 Free article. French.

6

[Ecteinascidin 743].

Lansiaux A, Bailly C. Lansiaux A, et al. Bull Cancer. 1999 Feb;86(2):139-41. Bull Cancer. 1999. PMID: 10094523 Free article. Review. French. No abstract available.

7

[An angiogenesis inhibitor: TNP-470].

Bailly C, Lansiaux A. Bailly C, et al. Among authors: lansiaux a. Bull Cancer. 2000 Jun;87(6):449-54. Bull Cancer. 2000. PMID: 10903786 Free article. French. No abstract available.

8

[JM216, an orally active platine derivative].

Lansiaux A, Bailly C. Lansiaux A, et al. Bull Cancer. 2000 Jul;87(7-8):531-6. Bull Cancer. 2000. PMID: 10969209 Free article. French. No abstract available.

9

[Flavopiridol, a cyclin-dependent kinase inhibitor].

Lansiaux A, Bailly C. Lansiaux A, et al. Bull Cancer. 2000 Oct;87(10):697-701. Bull Cancer. 2000. PMID: 11084532 Free article. Review. French. No abstract available.

10

Mechanisms underlying resistance to cetuximab in the HNSCC cell line: role of AKT inhibition in bypassing this resistance.

Rebucci M, Peixoto P, Dewitte A, Wattez N, De Nuncques MA, Rezvoy N, Vautravers-Dewas C, Buisine MP, Guerin E, Peyrat JP, Lartigau E, Lansiaux A. Rebucci M, et al. Among authors: lansiaux a. Int J Oncol. 2011 Jan;38(1):189-200. Int J Oncol. 2011. PMID: 21109940

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

103 results

Search Page

Filters